APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 18 analysts with an average price target of $45.72. This is a potential upside of $15.67 (52.15%) from yesterday's end of day stock price of $30.05.

Apellis Pharmaceuticals's activity chart (see below) currently has 411 price targets and 296 ratings on display. The stock rating distribution of APLS is 53.19% HOLD, 44.68% BUY and 2.13% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.94% with an average time for these price targets to be met of 199.33 days.

Highest price target for APLS is $60, Lowest price target is $18, average price target is $33.24.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 14-Oct-2025. First documented stock forecast 03-Dec-2017.

Currently out of the existing stock ratings of APLS, 25 are a HOLD (53.19%), 21 are a BUY (44.68%), 1 are a SELL (2.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$32

$3.83 (13.60%)

$29

15 days ago
(14-Oct-2025)

9/14 (64.29%)

$6.77 (26.83%)

110

Buy

$32

$3.83 (13.60%)

$81

15 days ago
(14-Oct-2025)

12/13 (92.31%)

$6.77 (26.83%)

94

Sell

$18

$-10.17 (-36.10%)

$32

1 months 4 days ago
(25-Sep-2025)

1/10 (10%)

$-4.37 (-19.54%)

24

Buy

$46

$17.83 (63.29%)

$41

3 months 1 days ago
(28-Jul-2025)

20/26 (76.92%)

$27.05 (142.74%)

216

Hold

$24

$-4.17 (-14.80%)

$23

3 months 14 days ago
(15-Jul-2025)

5/10 (50%)

$4.25 (21.52%)

29

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 199.33 days on average for the stock forecasts to be realized with a an average price target met ratio 64.94

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at RAYMOND JAMES and has 4 price targets and 3 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $112.83

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$10.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?